Beijing Aosaikang Pharmaceutical (002755.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue of 9 billion yuan...
ZhItong Finance APP News, Beijing Aosaikang Pharmaceutical (002755.SZ) released its semi-annual report for 2024. During the reporting period, the company achieved revenue of 0.923 billion yuan, a year-on-year growth of 29.60%. The net income attributable to shareholders of the listed company was 75.5945 million yuan. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 55.1349 million yuan. The earnings per share were 0.08 yuan.